Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome

OBJECTIVE—Dysregulated apolipoprotein (apo)C-III metabolism may account for hypertriglyceridemia and increased cardiovascular risk in the metabolic syndrome. This study investigated the dose-dependent effect of rosuvastatin on VLDL apoC-III transport in men with the metabolic syndrome. RESEARCH DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooi, Esther M.M., Watts, Gerald F., Chan, Dick C., Chen, Meifania M., Nestel, Paul J., Sviridov, Dmitri, Barrett, P. Hugh R.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494658/
https://www.ncbi.nlm.nih.gov/pubmed/18509206
http://dx.doi.org/10.2337/dc08-0358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494658/
https://www.ncbi.nlm.nih.gov/pubmed/18509206
http://dx.doi.org/10.2337/dc08-0358

Ejemplares similares